Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$963M |
| 3 |
Wells Fargo
WFC
|
+$647M |
| 4 |
ConocoPhillips
COP
|
+$632M |
| 5 |
UnitedHealth
UNH
|
+$490M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$907M |
| 3 |
KKR & Co
KKR
|
+$906M |
| 4 |
CRH
CRH
|
+$670M |
| 5 |
Meta Platforms (Facebook)
META
|
+$593M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.49% |
| 2 | Technology | 10.44% |
| 3 | Healthcare | 8.01% |
| 4 | Financials | 6.79% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARIS
3276
DELISTED
Aris Water Solutions
ARIS
| $2.35M | ﹤0.01% |
150,213
+88,473
| +143% | +$1.32M |
|
3277
C4 Therapeutics
CCCC
$474M
| $2.35M | ﹤0.01% |
509,406
-65,725
| -11% | -$392K |
|
3278
PUT
Cardinal Health
CAH
$54.6B
| $2.35M | ﹤0.01% |
23,900
-12,400
| -34% | -$1.26M |
|
|
MOMO
3279
Hello Group
MOMO
$845M
| $2.35M | ﹤0.01% |
383,888
-723,261
| -65% | -$4.22M |
|
3280
CALL
Zebra Technologies
ZBRA
$16.9B
| $2.35M | ﹤0.01% |
7,600
-2,300
| -23% | -$699K |
|
3281
AST SpaceMobile
ASTS
$17.4B
| $2.35M | ﹤0.01% |
+202,100
| New | +$1.06M |
|
3282
AMC Global Media
AMCX
$522M
| $2.34M | ﹤0.01% |
242,445
-61,502
| -20% | -$811K |
|
3283
CALL
Bentley Systems
BSY
$11.3B
| $2.34M | ﹤0.01% |
+47,400
| New | +$2.46M |
|
3284
Charles River Laboratories
CRL
$13.9B
| $2.34M | ﹤0.01% |
11,323
-124,737
| -92% | -$28.3M |
|
3285
PUT
Amphenol
APH
$194B
| $2.34M | ﹤0.01% |
34,700
+20,900
| +151% | +$1.32M |
|
3286
CALL
Sea Limited
SE
$73.1B
| $2.34M | ﹤0.01% |
32,700
-90,500
| -73% | -$5.98M |
|
3287
Compañía de Cervecerías Unidas
CCU
$2.23B
| $2.34M | ﹤0.01% |
205,197
-354,528
| -63% | -$4.36M |
|
3288
CALL
Alcoa
AA
$13.3B
| $2.34M | ﹤0.01% |
58,700
+43,400
| +284% | +$1.68M |
|
3289
Microvast
MVST
$278M
| $2.33M | ﹤0.01% |
5,104,829
+3,658,033
| +253% | +$1.64M |
|
3290
CALL
Vertiv
VRT
$99B
| $2.32M | ﹤0.01% |
26,800
+20,800
| +347% | +$1.89M |
|
3291
CALL
Nordson
NDSN
$18.1B
| $2.32M | ﹤0.01% |
+10,000
| New | +$2.52M |
|
3292
PUT
Jacobs Solutions
J
$17.8B
| $2.32M | ﹤0.01% |
20,069
+16,442
| +453% | +$1.93M |
|
3293
PUT
Exelixis
EXEL
$13.5B
| $2.32M | ﹤0.01% |
+103,200
| New | +$2.29M |
|
3294
Mercantile Bank Corp
MBWM
$1.04B
| $2.32M | ﹤0.01% |
57,138
+24,349
| +74% | +$912K |
|
|
DAWN
3295
DELISTED
Day One Biopharmaceuticals
DAWN
| $2.31M | ﹤0.01% |
167,765
+138,757
| +478% | +$2.03M |
|
3296
CALL
Cintas
CTAS
$81.7B
| $2.31M | ﹤0.01% |
13,200
-106,000
| -89% | -$18.1M |
|
3297
Dow Inc
DOW
$22B
| $2.31M | ﹤0.01% |
43,548
-787,610
| -95% | -$45M |
|
3298
uniQure
QURE
$3.38B
| $2.31M | ﹤0.01% |
515,221
+40,642
| +9% | +$198K |
|
3299
Herc Holdings
HRI
$5.03B
| $2.31M | ﹤0.01% |
+17,304
| New | +$2.56M |
|
|
KRON
3300
DELISTED
Kronos Bio
KRON
| $2.3M | ﹤0.01% |
1,857,988
+30,265
| +2% | +$30.8K |
|
Similar funds
Israel Englander's Q2 2024 Portfolio in Review
As of Q2 2024, Israel Englander held 6,803 positions worth $216B, down 7.8% from $234B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Israel Englander's Q2 2024 filing shows 661 new, 2,109 increased, 2,549 reduced and 995 closed positions. Its largest new stake was QXO Inc: 2,219,158 shares worth $20.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $963M.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2024 buy was QXO Inc: 2,219,158 shares worth $20.6M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $1.12B increase.
- Israel Englander's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $963M.
- Israel Englander fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $907M.
- Israel Englander's ten largest holdings make up 16% of its $216B portfolio in Q2 2024.
- Israel Englander opened 661 new positions and closed 995 in Q2 2024.
- Israel Englander's portfolio value fell 7.8% quarter-over-quarter to $216B.
Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.